Together Beyond COVID-19
To get answers to your COVID-19 questions, why not #AskTheExperts at PharmaLex?
We find ourselves in one of the most challenging situations in history. In a very short time, the world has been consumed by a virus that has proved to be both ruthless and deadly. Countries all over the world are battling an invisible enemy and yet remain resolute in the face of such adversity.
COVID-19 is evolving daily and represents an enormous challenge to public health, society and organizations seeking to maintain business operations. It is therefore imperative that we are able to react quickly and effectively. As a company we are closely monitoring the situation and have set-up a taskforce to recommend and communicate how we can take consistent approaches together to support our clients, protect our employees and our business during this pandemic. We see this as an opportunity to learn, grow, innovate and increase in flexibility. This is beyond corporate social responsibility, it’s way more – both as healthcare professionals and individuals. Our combined expertise can really make a difference and we are committed to going above and beyond to fight this as an industry.
However, despite the current crisis, product development continues and regulatory compliance, quality management and on-going pharmacovigilance must be maintained. It is important to also look beyond COVID-19 and have a strategy in place to manage this. Planning at a local level will help boost resources and ensure delivery plans are aligned when the time comes. Now is the opportunity to put in place fail-safe measures that will ensure business can continue now and will continue and grow when the crisis is over.
It is in times such as these that we can ensure that we work together. We are proud that we continue to support our clients and provide the necessary backbone which allows our industry to deliver.
Our approach is straightforward – we have experts across the globe who understand the current challenges and deliver solutions remotely. Our experts are available to answer your questions #AskTheExpert. Our IT infrastructure includes cloud-based technologies, and now more than ever, we see its value. Whilst on-site services are inevitably affected, our flexible team of committed experts is tailoring our solutions to your changing circumstances and has adopted a virtual approach wherever possible to deliver now and BEYONDCOVID19 – business continuity.
We remain dedicated to ensuring our clients can continue their vital work at a time when it is needed more than ever. Together Beyond COVID-19.
“How to mitigate manufacturing site closures?”
“What to do when clinical trials are closed / postponed?”
“How to manage interruptions or slow-down of business processes?”
“What are the alternatives to face-to-face audits?”
“Are frozen budgets affecting development strategy?”
“How to maintain legacy portfolios without necessary resource?”
“Getting a slower response from regulators?”
“How to plan recruitment for post-crisis back-log of work?”
Related PharmaLex News
COVID-19 Authority Updates
Our client commitment
In these unprecedented times, PharmaLex continues to support all clients by meeting virtually and providing experienced, remote-based consultants.